{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:27:15Z","timestamp":1783348035747,"version":"3.54.6"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014162","name":"Queen Mary Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014162","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BBSRC Queen Mary Impact Fund Award"},{"name":"Barts Centre for Squamous Cancer funded by Barts Charity","award":["G-002030"],"award-info":[{"award-number":["G-002030"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Early diagnosis of oral squamous cell carcinoma (OSCC) is critical, yet most oral potentially malignant disorders (OPMDs) are benign, and patients frequently undergo unnecessary invasive scalpel biopsies, creating diagnostic delays and patient harm. A rapid, non-invasive molecular diagnostic tool could improve early detection and reduce unnecessary procedures. This study aims to determine whether a previously validated microbiopsy-based multigene assay (qMIDS\n                      <jats:sup>V2<\/jats:sup>\n                      ) could be adapted into a rapid, non-invasive brush biopsy test (qMIDS\n                      <jats:sup>V3<\/jats:sup>\n                      ) for accurate OSCC detection. A prespecified hypothesis was that qMIDS\n                      <jats:sup>V3<\/jats:sup>\n                      could distinguish OSCC from low-risk OPMD and contralateral normal mucosa with high diagnostic sensitivity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This prospective diagnostic case-control study validated a multigene mRNA test (qMIDS\n                      <jats:sup>V3<\/jats:sup>\n                      ) for OSCC detection using 1090 oral brush biopsies from 545 patients. Each patient provided paired brush biopsies from oral lesion and contralateral non-lesion mucosa, including OSCC (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009443), oral leukoplakia (OL;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200963), and oral lichen planus (OLP;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200939). qPCR quantified mRNA levels of four genes (\n                      <jats:italic>INHBA<\/jats:italic>\n                      ,\n                      <jats:italic>S100A16<\/jats:italic>\n                      ,\n                      <jats:italic>YAP1<\/jats:italic>\n                      ,\n                      <jats:italic>POLR2A<\/jats:italic>\n                      ) from each brush biopsy, and an algorithm generated a malignancy index for cancer risk stratification.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      qMIDS\n                      <jats:sup>V3<\/jats:sup>\n                      distinguished OSCC from OL and OLP with AUC 0.975, sensitivity 95.7%, specificity 95.1%, and overall accuracy 95.5%. False-positive and false-negative rates were 4.9% and 4.3%, demonstrating high specificity for detecting malignant cells rather than premalignant or inflammatory lesions.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our findings highlight the clinical utility of qMIDS\n                      <jats:sup>V3<\/jats:sup>\n                      as a rapid case-finding or triage test, potentially sparing over 90% of low-risk OPMD patients from unnecessary invasive tissue biopsies while accurately identifying OSCC cases. Non-invasive brush biopsy allows safe, repeatable sampling for long-term surveillance with minimal patient harm and enhancing early oral cancer detection. By reducing unnecessary scalpel biopsies and specialty referrals, qMIDS\n                      <jats:sup>V3<\/jats:sup>\n                      provides a molecularly guided and rapid triage pathway.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40364-026-00963-7","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:44:13Z","timestamp":1782233053000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["INHBA\u2013S100A16 dysregulation enables a non-invasive molecular stratification platform for rapid detection of oral squamous cell carcinoma: results from a large diagnostic case-control study"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7725-8355","authenticated-orcid":false,"given":"Muy-Teck","family":"Teh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjitkumar","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyajit Ashok","family":"Tekade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilanand","family":"Chaurasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Waseem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"10512","key":"963_CR1","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1016\/S0140-6736(25)01635-6","volume":"406","author":"GBDC Collaborators","year":"2025","unstructured":"Collaborators GBDC. The global, regional, and national burden of cancer, 1990\u20132023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406(10512):1565\u201386.","journal-title":"Lancet"},{"issue":"3","key":"963_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"963_CR3","doi-asserted-by":"publisher","first-page":"e0320184","DOI":"10.1371\/journal.pone.0320184","volume":"20","author":"Q Hu","year":"2025","unstructured":"Hu Q, Lv S, Wang X, Pan P, Gong W, Mei J. Global burden and future trends of head and neck cancer: a deep learning-based analysis (1980\u20132030). PLoS ONE. 2025;20(4):e0320184.","journal-title":"PLoS ONE"},{"issue":"10513","key":"963_CR4","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","volume":"406","author":"GBDCD Collaborators","year":"2025","unstructured":"Collaborators GBDCD. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406(10513):1811\u201372.","journal-title":"Lancet"},{"issue":"10","key":"963_CR5","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.bjoms.2015.08.263","volume":"53","author":"PJ Thomson","year":"2015","unstructured":"Thomson PJ, McCaul JA, Ridout F, Hutchison IL. To treat\u2026 or not to treat? Clinicians\u2019 views on the management of oral potentially malignant disorders. Br J Oral Maxillofac Surg. 2015;53(10):1027\u201331.","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"7","key":"963_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/odi.12428","volume":"22","author":"LJ Jin","year":"2016","unstructured":"Jin LJ, Lamster IB, Greenspan JS, Pitts NB, Scully C, Warnakulasuriya S. Global burden of oral diseases: emerging concepts, management and interplay with systemic health. Oral Dis. 2016;22(7):609\u201319.","journal-title":"Oral Dis"},{"issue":"5","key":"963_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.oooo.2015.07.036","volume":"120","author":"JB Epstein","year":"2015","unstructured":"Epstein JB, Huber MA. The benefit and risk of screening for oral potentially malignant epithelial lesions and squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;120(5):537\u201340.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"1","key":"963_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/odi.12208","volume":"20","author":"C Scully","year":"2014","unstructured":"Scully C. Challenges in predicting which oral mucosal potentially malignant disease will progress to neoplasia. Oral Dis. 2014;20(1):1\u20135.","journal-title":"Oral Dis"},{"key":"963_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-3284-3-33","volume":"3","author":"R Mehrotra","year":"2011","unstructured":"Mehrotra R, Gupta DK. Exciting new advances in oral cancer diagnosis: avenues to early detection. Head Neck Oncol. 2011;3:33.","journal-title":"Head Neck Oncol"},{"key":"963_CR10","doi-asserted-by":"publisher","first-page":"104550","DOI":"10.1016\/j.oraloncology.2019.104550","volume":"102","author":"S Warnakulasuriya","year":"2020","unstructured":"Warnakulasuriya S. Oral potentially malignant disorders: A comprehensive review on clinical aspects and management. Oral Oncol. 2020;102:104550.","journal-title":"Oral Oncol"},{"issue":"7","key":"963_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/jop.12726","volume":"47","author":"FW Mello","year":"2018","unstructured":"Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, Rivero ERC. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med. 2018;47(7):633\u201340.","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"963_CR12","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/hed.26006","volume":"42","author":"O Iocca","year":"2020","unstructured":"Iocca O, Sollecito TP, Alawi F, Weinstein GS, Newman JG, De Virgilio A, Di Maio P, Spriano G, Pardinas Lopez S, Shanti RM. Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42(3):539\u201355.","journal-title":"Head Neck"},{"issue":"7","key":"963_CR13","first-page":"CD010276","volume":"7","author":"T Walsh","year":"2021","unstructured":"Walsh T, Macey R, Kerr AR, Lingen MW, Ogden GR, Warnakulasuriya S. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane database Syst reviews (Online). 2021;7(7):CD010276.","journal-title":"Cochrane database Syst reviews (Online)"},{"issue":"8","key":"963_CR14","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1111\/odi.13993","volume":"27","author":"E Odell","year":"2021","unstructured":"Odell E, Kujan O, Warnakulasuriya S, Sloan P. Oral epithelial dysplasia: Recognition, grading and clinical significance. Oral Dis. 2021;27(8):1947\u201376.","journal-title":"Oral Dis"},{"issue":"1","key":"963_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.oraloncology.2007.06.011","volume":"44","author":"MW Lingen","year":"2008","unstructured":"Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008;44(1):10\u201322.","journal-title":"Oral Oncol"},{"issue":"4","key":"963_CR16","first-page":"199","volume":"21","author":"C Scully","year":"2008","unstructured":"Scully C, Bagan JV, Hopper C, Epstein JB. Oral cancer: current and future diagnostic techniques. Am J Dent. 2008;21(4):199\u2013209.","journal-title":"Am J Dent"},{"key":"963_CR17","doi-asserted-by":"crossref","unstructured":"Gonzalez-Ruiz I, Ramos-Garcia P, Ruiz-Avila I, Gonzalez-Moles MA. Early diagnosis of oral cancer: a complex polyhedral problem with a difficult solution. Cancers (Basel). 2023;15(13).","DOI":"10.3390\/cancers15133270"},{"issue":"Suppl 1","key":"963_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1834-7819.2010.01200.x","volume":"55","author":"MJ McCullough","year":"2010","unstructured":"McCullough MJ, Prasad G, Farah CS. Oral mucosal malignancy and potentially malignant lesions: an update on the epidemiology, risk factors, diagnosis and management. Aust Dent J. 2010;55(Suppl 1):61\u20135.","journal-title":"Aust Dent J"},{"issue":"12","key":"963_CR19","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/hed.21131","volume":"31","author":"HM Mehanna","year":"2009","unstructured":"Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis. Head Neck. 2009;31(12):1600\u20139.","journal-title":"Head Neck"},{"key":"963_CR20","doi-asserted-by":"publisher","first-page":"m4087","DOI":"10.1136\/bmj.m4087","volume":"371","author":"TP Hanna","year":"2020","unstructured":"Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, O\u2019Sullivan DE, Booth CM, Sullivan R, Aggarwal A. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020;371:m4087.","journal-title":"BMJ"},{"issue":"9","key":"963_CR21","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1002\/ijc.27886","volume":"132","author":"MT Teh","year":"2013","unstructured":"Teh MT, Hutchison IL, Costea DE, Neppelberg E, Liavaag PG, Purdie K, Harwood C, Wan H, Odell EW, Hackshaw A, et al. Exploiting FOXM1-orchestrated molecular network for early squamous cell carcinoma diagnosis and prognosis. Int J Cancer. 2013;132(9):2095\u2013106.","journal-title":"Int J Cancer"},{"issue":"34","key":"963_CR22","doi-asserted-by":"publisher","first-page":"54555","DOI":"10.18632\/oncotarget.10512","volume":"7","author":"H Ma","year":"2016","unstructured":"Ma H, Dai H, Duan X, Tang Z, Liu R, Sun K, Zhou K, Chen H, Xiang H, Wang J, et al. Independent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomas. Oncotarget. 2016;7(34):54555\u201363.","journal-title":"Oncotarget"},{"issue":"6","key":"963_CR23","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/cancers14061389","volume":"14","author":"MT Teh","year":"2022","unstructured":"Teh MT, Ma H, Liang YY, Solomon MC, Chaurasia A, Patil R, Tekade SA, Mishra D, Qadir F, Yeung JS, et al. Molecular Signatures of Tumour and Its Microenvironment for Precise Quantitative Diagnosis of Oral Squamous Cell Carcinoma: An International Multi-Cohort Diagnostic Validation Study. Cancers (Basel). 2022;14(6):1389.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"963_CR24","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/hed.70148","volume":"48","author":"JC Gates","year":"2026","unstructured":"Gates JC, Edwards H, Villa A, Purdy N, Troka M, Varela P, Self Q, Liu Y, Dundar Y, Brooks PJ, et al. Biopsy for Suspicious Oral Lesions: A Review From the American Head and Neck Society-Cancer Prevention Service. Head Neck. 2026;48(3):884\u201392.","journal-title":"Head Neck"},{"issue":"9","key":"963_CR25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/cncy.22599","volume":"130","author":"M Idrees","year":"2022","unstructured":"Idrees M, Farah CS, Sloan P, Kujan O. Oral brush biopsy using liquid-based cytology is a reliable tool for oral cancer screening: A cost-utility analysis: Oral brush biopsy for oral cancer screening. Cancer Cytopathol. 2022;130(9):740\u20138.","journal-title":"Cancer Cytopathol"},{"key":"963_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1758-3284-3-39","volume":"3","author":"R Mehrotra","year":"2011","unstructured":"Mehrotra R, Mishra S, Singh M, Singh M. The efficacy of oral brush biopsy with computer-assisted analysis in identifying precancerous and cancerous lesions. Head Neck Oncol. 2011;3:39.","journal-title":"Head Neck Oncol"},{"issue":"4","key":"963_CR27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611\u201322.","journal-title":"Clin Chem"},{"issue":"8","key":"963_CR28","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1089\/cmb.2005.12.1047","volume":"12","author":"S Zhao","year":"2005","unstructured":"Zhao S, Fernald RD. Comprehensive algorithm for quantitative real-time polymerase chain reaction. J Comput Biol. 2005;12(8):1047\u201364.","journal-title":"J Comput Biol"},{"key":"963_CR29","doi-asserted-by":"crossref","unstructured":"Liang Y, Mo Z, Teh MT. A multigene signature for prognostic stratification of nasopharyngeal carcinoma. Cancers (Basel). 2026;18(8).","DOI":"10.3390\/cancers18081197"},{"key":"963_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M. pROC: an open-source package for R and S\u2009+\u2009to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.","journal-title":"BMC Bioinformatics"},{"key":"963_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1472-6947-6-16","volume":"6","author":"A Schwartz","year":"2006","unstructured":"Schwartz A, Millam G, Investigators UL. A web-based library consult service for evidence-based medicine: Technical development. BMC Med Inf Decis Mak. 2006;6:16.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"4","key":"963_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S1470-2045(10)70018-8","volume":"11","author":"N Juul","year":"2010","unstructured":"Juul N, Szallasi Z, Eklund AC, Li Q, Burrell RA, Gerlinger M, Valero V, Andreopoulou E, Esteva FJ, Symmans WF, et al. Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials. Lancet Oncol. 2010;11(4):358\u201365.","journal-title":"Lancet Oncol"},{"key":"963_CR33","doi-asserted-by":"publisher","first-page":"155105","DOI":"10.1016\/j.cyto.2020.155105","volume":"133","author":"E Appiah Adu-Gyamfi","year":"2020","unstructured":"Appiah Adu-Gyamfi E, Tanam Djankpa F, Nelson W, Czika A, Kumar Sah S, Lamptey J, Ding YB, Wang YX. Activin and inhibin signaling: From regulation of physiology to involvement in the pathology of the female reproductive system. Cytokine. 2020;133:155105.","journal-title":"Cytokine"},{"key":"963_CR34","doi-asserted-by":"crossref","unstructured":"Bhattarai BP, Singh AK, Singh RP, Chaulagain R, Soland TM, Hasseus B, Sapkota D. Recurrence in oral leukoplakia: A systematic review and meta-analysis. J Dent Res. 2024;103:220345241266519.","DOI":"10.1177\/00220345241266519"},{"key":"963_CR35","doi-asserted-by":"crossref","unstructured":"Cirillo N. Precursor lesions, overdiagnosis, and oral cancer: a critical review. Cancers (Basel). 2024;16(8).","DOI":"10.3390\/cancers16081550"},{"issue":"8","key":"963_CR36","first-page":"1727","volume":"63","author":"BJ Braakhuis","year":"2003","unstructured":"Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH. A genetic explanation of Slaughter\u2019s concept of field cancerization: evidence and clinical implications. Cancer Res. 2003;63(8):1727\u201330.","journal-title":"Cancer Res"},{"issue":"12","key":"963_CR37","doi-asserted-by":"publisher","first-page":"14029","DOI":"10.18632\/oncotarget.7373","volume":"7","author":"A Khammanivong","year":"2016","unstructured":"Khammanivong A, Sorenson BS, Ross KF, Dickerson EB, Hasina R, Lingen MW, Herzberg MC. Involvement of calprotectin (S100A8\/A9) in molecular pathways associated with HNSCC. Oncotarget. 2016;7(12):14029\u201347.","journal-title":"Oncotarget"},{"issue":"24","key":"963_CR38","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.1158\/0008-5472.CAN-16-1188","volume":"76","author":"WM Chang","year":"2016","unstructured":"Chang WM, Lin YF, Su CY, Peng HY, Chang YC, Lai TC, Wu GH, Hsu YM, Chi LH, Hsiao JR, et al. Dysregulation of RUNX2\/Activin-A Axis upon miR-376c Downregulation Promotes Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma. Cancer Res. 2016;76(24):7140\u201350.","journal-title":"Cancer Res"},{"key":"963_CR39","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1186\/s12885-015-1622-1","volume":"15","author":"D Sapkota","year":"2015","unstructured":"Sapkota D, Bruland O, Parajuli H, Osman TA, Teh MT, Johannessen AC, Costea DE. S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma. BMC Cancer. 2015;15:631.","journal-title":"BMC Cancer"},{"issue":"1","key":"963_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-023-01846-3","volume":"22","author":"N Khera","year":"2023","unstructured":"Khera N, Rajkumar AS, Abdulkader MAK, Liu Z, Ma H, Waseem A, Teh MT. Identification of multidrug chemoresistant genes in head and neck squamous cell carcinoma cells. Mol Cancer. 2023;22(1):146.","journal-title":"Mol Cancer"},{"key":"963_CR41","doi-asserted-by":"crossref","unstructured":"Basnet S, Vallenari EM, Maharjan U, Sharma S, Schreurs O, Sapkota D. An update on S100A16 in human cancer. Biomolecules. 2023;13(7).","DOI":"10.3390\/biom13071070"},{"issue":"8","key":"963_CR42","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1017\/S0022215114001406","volume":"128","author":"C Williams","year":"2014","unstructured":"Williams C, Byrne R, Holden D, Sherman I, Srinivasan VR. Two-week referrals for suspected head and neck cancer: two cycles of audit, 10 years apart, in a district general hospital. J Laryngol Otol. 2014;128(8):720\u20134.","journal-title":"J Laryngol Otol"},{"issue":"8","key":"963_CR43","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1017\/S002221511900149X","volume":"133","author":"C Gao","year":"2019","unstructured":"Gao C, Qin C, Freeman S, Oskooee N, Hughes J. Two week wait referral criteria - heading in the right direction? J Laryngol Otol. 2019;133(8):704\u201312.","journal-title":"J Laryngol Otol"},{"key":"963_CR44","doi-asserted-by":"publisher","first-page":"104955","DOI":"10.1016\/j.oraloncology.2020.104955","volume":"109","author":"SE Scott","year":"2020","unstructured":"Scott SE, Oakley R, Moller H, Warburton F. Tracking cancer occurrence in the 5 years after referral for suspected head and neck cancer. Oral Oncol. 2020;109:104955.","journal-title":"Oral Oncol"},{"issue":"12","key":"963_CR45","first-page":"CD010173","volume":"12","author":"T Walsh","year":"2021","unstructured":"Walsh T, Warnakulasuriya S, Lingen MW, Kerr AR, Ogden GR, Glenny AM, Macey R. Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane database Syst reviews (Online). 2021;12(12):CD010173.","journal-title":"Cochrane database Syst reviews (Online)"},{"issue":"11","key":"963_CR46","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.adaj.2017.08.045","volume":"148","author":"MW Lingen","year":"2017","unstructured":"Lingen MW, Tampi MP, Urquhart O, Abt E, Agrawal N, Chaturvedi AK, Cohen E, D\u2019Souza G, Gurenlian J, Kalmar JR, et al. Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: Diagnostic test accuracy systematic review and meta-analysis-a report of the American Dental Association. J Am Dent Assoc (1939). 2017;148(11):797\u2013813. e752.","journal-title":"J Am Dent Assoc (1939)"},{"key":"963_CR47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jdsr.2023.12.004","volume":"60","author":"J Lau","year":"2024","unstructured":"Lau J, O G, Warnakulasuriya S, Balasubramaniam R, Frydrych A, Kujan O. Adjunctive aids for the detection of oral squamous cell carcinoma and oral potentially malignant disorders: A systematic review of systematic reviews. Jpn Dent Sci Rev. 2024;60:53\u201372.","journal-title":"Jpn Dent Sci Rev"},{"key":"963_CR48","doi-asserted-by":"publisher","first-page":"1505833","DOI":"10.3389\/froh.2024.1505833","volume":"5","author":"RD Coletta","year":"2024","unstructured":"Coletta RD, Yeudall WA, Salo T. Current trends on prevalence, risk factors and prevention of oral cancer. Front Oral Health. 2024;5:1505833.","journal-title":"Front Oral Health"},{"key":"963_CR49","doi-asserted-by":"publisher","first-page":"615099","DOI":"10.3389\/fmed.2021.615099","volume":"8","author":"Y Mardian","year":"2021","unstructured":"Mardian Y, Kosasih H, Karyana M, Neal A, Lau CY. Review of Current COVID-19 Diagnostics and Opportunities for Further Development. Front Med (Lausanne). 2021;8:615099.","journal-title":"Front Med (Lausanne)"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-00963-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00963-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00963-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:09:48Z","timestamp":1783346988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-00963-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["963"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-00963-7","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research protocol for our study was approved by the relevant Research Ethics Committee at each institution: Queen Mary University of London (UK NREC:06\/MRE03\/69 and QMERC20.142); King George\u2019s Medical University, India (104th ECM IIA\/P18) and the study was conducted in accordance with the Declaration of Helsinki. All clinical samples were collected according to approved protocol and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"M.T.T. declared that patents have been filed by QM Innovation Ltd for the qMIDS technology (PCT\/EP2020\/070689, US20230133776 and GB2512759.8), covering its methodology and clinical applications. No disclosures were reported by the other authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"76"}}